Latest filing published 28 Sept 2020 for Principia Biopharma Inc., €325k.
Christopher Y. Chai is a declared insider of Principia Biopharma Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 18 February 2020 to 28 September 2020, the count stands at 13 filings.
Every open-market trade on record is a sale: 8 sales worth €1.5M. Outside the open market, there are 3 option exercises.
The record was last updated on 28 September 2020 with a transaction (€325k) in Principia Biopharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations